The Auxiliary Effects of Low-Molecular-Weight Fucoidan in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy Before Surgery: A Double-Blind, Randomized, Placebo-Controlled Study

Patients with cancer use low-molecular-weight fucoidan (LMF) as a supplement to therapy. However, most studies of LMF are in vitro or conducted using animals. Concurrent chemoradiotherapy (CCRT) is the gold standard for locally advanced rectal cancer (LARC). This study investigated the quality of li...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hsiang-Lin, Yeh, Yung-Sung, Chen, Po-Jung, Chang, Yu-Tang, Chen, Yen-Cheng, Su, Wei-Chih, Chang, Tsung-Kun, Huang, Ching-Wen, Wang, Jaw-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571697/
https://www.ncbi.nlm.nih.gov/pubmed/37822243
http://dx.doi.org/10.1177/15347354231187153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571697/
https://www.ncbi.nlm.nih.gov/pubmed/37822243
http://dx.doi.org/10.1177/15347354231187153

Ejemplares similares